Literature DB >> 19341827

Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better?

Stéphane Roche1, Laurent Tiers, Monique Provansal, Martial Seveno, Marie-Thérèse Piva, Patrick Jouin, Sylvain Lehmann.   

Abstract

Depletion of major blood proteins is one of the most promising approaches to access low abundant biomarkers using proteomics. Immunocapture columns often used for this purpose exist in different formats depending on the number of major proteins removed. In this article, we compared the relative interest of depleting either one (albumin), six (albumin, IgG, IgA, transferrin, alpha1-antitrypsin, and haptoglobin), twelve (the previous six and apo A-I and -II, orosomucoid, alpha2-macroglobulin, fibrinogen, IgM) or twenty blood proteins (the previous twelve and IgD, ceruloplasmin, apo B, complement C1q, C3, C4, plasminogen, and prealbumin). Such study raises interesting issues related to the reproducibility, practicability, specificity of the immunocapture, and to the impact of removing not only the selected molecules, but also associated peptides and proteins. Depleted sera were here analysed using different proteomic approaches, including two dimensional electrophoresis and SELDI-TOF. Altogether, our results clearly confirmed the interest of depleting major blood proteins for the proteomic detection of low abundant components. However, we observed that increasing the number of depleted proteins from twelve to twenty had a limited beneficial impact and might increase drawbacks in removing associated peptides and proteins. This conclusion is however related to the technologies that we have used, and we believe that it is necessary to adapt the immunocapture to the analytical method employed, and to the ratio between wanted and unwanted proteins removed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341827     DOI: 10.1016/j.jprot.2009.03.008

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  27 in total

1.  One-step sample concentration, purification, and albumin depletion method for urinary proteomics.

Authors:  Ali R Vaezzadeh; Andrew C Briscoe; Hanno Steen; Richard S Lee
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

2.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

3.  Depletion of abundant plasma proteins and limitations of plasma proteomics.

Authors:  Chengjian Tu; Paul A Rudnick; Misti Y Martinez; Kristin L Cheek; Stephen E Stein; Robbert J C Slebos; Daniel C Liebler
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

4.  Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.

Authors:  Sheng Pan; Ru Chen; David A Crispin; Damon May; Tyler Stevens; Martin W McIntosh; Mary P Bronner; Argyrios Ziogas; Hoda Anton-Culver; Teresa A Brentnall
Journal:  J Proteome Res       Date:  2011-03-28       Impact factor: 4.466

Review 5.  Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  Electrophoresis       Date:  2011-11-28       Impact factor: 3.535

6.  Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Authors:  Xuefeng B Ling; Jane L Park; Tanya Carroll; Khoa D Nguyen; Kenneth Lau; Claudia Macaubas; Edward Chen; Tzielan Lee; Christy Sandborg; Diana Milojevic; John T Kanegaye; Susanna Gao; Jane Burns; James Schilling; Elizabeth D Mellins
Journal:  Proteomics       Date:  2010-11-23       Impact factor: 3.984

7.  The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays.

Authors:  Jochen M Schwenk; Gilbert S Omenn; Zhi Sun; David S Campbell; Mark S Baker; Christopher M Overall; Ruedi Aebersold; Robert L Moritz; Eric W Deutsch
Journal:  J Proteome Res       Date:  2017-10-10       Impact factor: 4.466

8.  Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis.

Authors:  Eslam N Nigjeh; Ru Chen; Randall E Brand; Gloria M Petersen; Suresh T Chari; Priska D von Haller; Jimmy K Eng; Ziding Feng; Qingxiang Yan; Teresa A Brentnall; Sheng Pan
Journal:  J Proteome Res       Date:  2017-01-03       Impact factor: 4.466

9.  Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.

Authors:  Brianna Kim; Robyn Araujo; Marissa Howard; Ruben Magni; Lance A Liotta; Alessandra Luchini
Journal:  Expert Rev Proteomics       Date:  2018-03-22       Impact factor: 3.940

10.  cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Authors:  Philipp Spitzer; Hans Wolfgang Klafki; Kaj Blennow; Luc Buée; Hermann Esselmann; Sanna-Kaisa Herruka; Connie Jimenez; Peter Klivenyi; Piotr Lewczuk; Juan Manuel Maler; Katrin Markus; Helmut E Meyer; Chris Morris; Thorsten Müller; Markus Otto; Lucilla Parnetti; Hilkka Soininen; Susanna Schraen; Charlotte Teunissen; Laszlo Vecsei; Henrik Zetterberg; Jens Wiltfang
Journal:  Int J Alzheimers Dis       Date:  2010-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.